Macquarie Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$105M Buy
926,554
+20,327
+2% +$2.31M 0.13% 215
2025
Q1
$95.3M Buy
906,227
+21,847
+2% +$2.3M 0.12% 245
2024
Q4
$94.8M Sell
884,380
-2,895
-0.3% -$310K 0.12% 248
2024
Q3
$88.8M Sell
887,275
-79,277
-8% -$7.93M 0.1% 285
2024
Q2
$81.4M Sell
966,552
-66,629
-6% -$5.61M 0.09% 279
2024
Q1
$75.5M Buy
1,033,181
+45,827
+5% +$3.35M 0.09% 302
2023
Q4
$70.5M Sell
987,354
-4,464
-0.5% -$319K 0.08% 340
2023
Q3
$59.4M Buy
991,818
+154,648
+18% +$9.27M 0.07% 351
2023
Q2
$60.4M Buy
837,170
+19,187
+2% +$1.38M 0.07% 367
2023
Q1
$60.2M Buy
817,983
+17,387
+2% +$1.28M 0.07% 351
2022
Q4
$53.5M Sell
800,596
-471,578
-37% -$31.5M 0.06% 421
2022
Q3
$68.3M Buy
1,272,174
+15,544
+1% +$835K 0.08% 328
2022
Q2
$69.9M Buy
1,256,630
+40,368
+3% +$2.25M 0.08% 348
2022
Q1
$85.4K Buy
1,216,262
+214,437
+21% +$15K 0.06% 345
2021
Q4
$96.5M Sell
1,001,825
-31,754
-3% -$3.06M 0.08% 314
2021
Q3
$89.8M Buy
1,033,579
+81,881
+9% +$7.12M 0.08% 334
2021
Q2
$77.9M Buy
951,698
+175,272
+23% +$14.3M 0.06% 382
2021
Q1
$73.8M Sell
776,426
-657,743
-46% -$62.6M 0.1% 245
2020
Q4
$89M Buy
1,434,169
+222,088
+18% +$13.8M 0.13% 172
2020
Q3
$72.1M Buy
1,212,081
+22,570
+2% +$1.34M 0.12% 179
2020
Q2
$83M Buy
1,189,511
+78,496
+7% +$5.48M 0.14% 148
2020
Q1
$50.4M Buy
1,111,015
+86,273
+8% +$3.91M 0.1% 208
2019
Q4
$66.7M Buy
1,024,742
+127,118
+14% +$8.27M 0.1% 225
2019
Q3
$55.7M Buy
897,624
+54,707
+6% +$3.4M 0.09% 228
2019
Q2
$60M Buy
842,917
+56,193
+7% +$4M 0.1% 209
2019
Q1
$61.7M Buy
786,724
+82,066
+12% +$6.44M 0.11% 192
2018
Q4
$59.7M Buy
704,658
+105,336
+18% +$8.92M 0.12% 170
2018
Q3
$103M Sell
599,322
-37,250
-6% -$6.38M 0.17% 104
2018
Q2
$82.3M Buy
636,572
+15,982
+3% +$2.07M 0.14% 134
2018
Q1
$63.9M Buy
620,590
+29,527
+5% +$3.04M 0.12% 163
2017
Q4
$50.5M Sell
591,063
-151,182
-20% -$12.9M 0.09% 214
2017
Q3
$63M Sell
742,245
-12,861
-2% -$1.09M 0.11% 162
2017
Q2
$57.2M Buy
755,106
+162,020
+27% +$12.3M 0.1% 162
2017
Q1
$39.2M Buy
593,086
+65,435
+12% +$4.32M 0.07% 248
2016
Q4
$33.4M Buy
527,651
+89,832
+21% +$5.69M 0.06% 278
2016
Q3
$27.9M Sell
437,819
-465,084
-52% -$29.6M 0.05% 322
2016
Q2
$67.2M Buy
902,903
+468,629
+108% +$34.9M 0.07% 240
2016
Q1
$29M Buy
434,274
+61,807
+17% +$4.13M 0.06% 272
2015
Q4
$25.2M Sell
372,467
-39,294
-10% -$2.66M 0.05% 292
2015
Q3
$22M Buy
411,761
+62,236
+18% +$3.33M 0.05% 321
2015
Q2
$22M Sell
349,525
-19,364
-5% -$1.22M 0.04% 346
2015
Q1
$17.7M Buy
368,889
+149,502
+68% +$7.19M 0.03% 405
2014
Q4
$7.28M Buy
219,387
+123,207
+128% +$4.09M 0.02% 607
2014
Q3
$2.82M Hold
96,180
0.01% 886
2014
Q2
$3.74M Hold
96,180
0.01% 803
2014
Q1
$4.04M Hold
96,180
0.01% 739
2013
Q4
$3.16M Sell
96,180
-81,272
-46% -$2.67M 0.01% 784
2013
Q3
$4.79M Sell
177,452
-22,923
-11% -$619K 0.01% 626
2013
Q2
$4.68M Buy
+200,375
New +$4.68M 0.01% 609